• PDF / 576,381 Bytes
• 6 Pages / 595.276 x 790.866 pts Page_size
• 96 Downloads / 196 Views

DOWNLOAD

REPORT

NEPHROLOGY - ORIGINAL PAPER

Serum apolipoprotein B/apolipoprotein A1 ratio is associated with the progression of diabetic kidney disease to renal replacement therapy Wen‑bo Zhao1   · De La Pena Serna Mario Alberto2 Received: 7 March 2020 / Accepted: 19 June 2020 © Springer Nature B.V. 2020

Abstract Purpose  The apolipoprotein B/apolipoprotein A1 (ApoB/ApoA1) ratio has been shown to be associated with cardiovascular disease risk and the progression of chronic kidney disease. The association between the ApoB/ApoA1 ratio and the progression of diabetic kidney disease (DKD) is not well studied. Methods  Patients with DKD were divided into four groups (

Recommend Documents

Enrichment of apolipoprotein A-IV and apolipoprotein D in the HDL proteome is associated with HDL functions in diabetic

147 33 1MB

The Genetic Basis of Diabetic Kidney Disease

188 33 27MB

Diabetic kidney disease and diabetic retinopathy: the ominous duo

161 62 127KB

Apolipoprotein E Polymorphism and Frailty: Apolipoprotein E4 Allele is Associated with Fatigue But Not Frailty Syndrome

190 107 707KB

Increasing serum alkaline phosphatase is associated with bone deformity progression for patients with polyostotic fibrou

156 96 2MB

Inflammatory Mechanisms in Diabetic Kidney Disease

159 97 27MB

Role of Senescent Renal Cells in Pathophysiology of Diabetic Kidney Disease

133 94 441KB

Mechanism of progression of diabetic kidney disease mediated by podocyte mitochondrial injury

151 109 2MB

Dicarbonyl-mediated AGEing and diabetic kidney disease

170 54 645KB

Kidney-gut crosstalk in renal disease

161 19 621KB

Diabetic kidney disease: the onset of a new era?

173 14 303KB

High RAD18 Expression is Associated with Disease Progression and Poor Prognosis in Patients with Gastric Cancer

167 73 5MB